Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Olson

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|November 28, 2024
Design of allosteric modulators that change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Abigail Alwin, et al.
Research Square|December 23, 2024
Design of allosteric modulators that change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Abigail Alwin, et al.
Molecular Cancer Therapeutics|January 9, 2015
The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic AgentsJude Canon, Tao Osgood, Steven H Olson, et al.
Nature|October 22, 2025
Designing allosteric modulators to change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Valeria L Robleto, et al.
Addiction Neuroscience|September 5, 2025
Biased allosteric modulator of neurotensin receptor 1 reduces ethanol drinking and responses to ethanol administration in rodentsGraydon B Gereau, Diana Zhou, Kalynn Van Voorhies, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
β-arrestin-biased Allosteric Modulator of Neurotensin Receptor 1 Reduces Ethanol Drinking and Responses to Ethanol Administration in RodentsGraydon B Gereau, Diana Zhou, Kalynn Van Voorhies, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2014
Optimization beyond AMG 232: discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein-protein interactionYingcai Wang, Jiang Zhu, Jiwen Jim Liu, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 ActivityJean-Marc M Grandjean, Alexander Y Jiu, John W West, et al.
Cell|May 20, 2025
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic painRan Guo, Ouyang Chen, Yang Zhou, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 InteractionMing Yu, Yingcai Wang, Jiang Zhu, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|November 28, 2024
Design of allosteric modulators that change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Abigail Alwin, et al.
Research Square|December 23, 2024
Design of allosteric modulators that change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Abigail Alwin, et al.
Molecular Cancer Therapeutics|January 9, 2015
The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic AgentsJude Canon, Tao Osgood, Steven H Olson, et al.
Nature|October 22, 2025
Designing allosteric modulators to change GPCR G protein subtype selectivityMadelyn N Moore, Kelsey L Person, Valeria L Robleto, et al.
Addiction Neuroscience|September 5, 2025
Biased allosteric modulator of neurotensin receptor 1 reduces ethanol drinking and responses to ethanol administration in rodentsGraydon B Gereau, Diana Zhou, Kalynn Van Voorhies, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
β-arrestin-biased Allosteric Modulator of Neurotensin Receptor 1 Reduces Ethanol Drinking and Responses to Ethanol Administration in RodentsGraydon B Gereau, Diana Zhou, Kalynn Van Voorhies, et al.
Bioorganic & Medicinal Chemistry Letters|July 22, 2014
Optimization beyond AMG 232: discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein-protein interactionYingcai Wang, Jiang Zhu, Jiwen Jim Liu, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 ActivityJean-Marc M Grandjean, Alexander Y Jiu, John W West, et al.
Cell|May 20, 2025
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic painRan Guo, Ouyang Chen, Yang Zhou, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 InteractionMing Yu, Yingcai Wang, Jiang Zhu, et al.
Pageof 5